Brief: Insilico Medicine Announces Industry's First Longevity Board To Accelerate Ai-Driven Aging Research For Drug Discovery
21/04/2026 14:08
Insilico Medicine Cayman TopCo 3696.HK: INSILICO MEDICINE ANNOUNCES INDUSTRY'S FIRST LONGEVITY BOARD TO ACCELERATE AI-DRIVEN AGING RESEARCH FOR DRUG DISCOVERY Source text: ID:nPn62ZCbCa Further company coverage: 3696.HK
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7